Japanese journal of clinical oncology
-
Jpn. J. Clin. Oncol. · Nov 2015
Review Meta AnalysisSystematic review and network meta-analysis: neoadjuvant chemoradiotherapy for locoregional esophageal cancer.
Neoadjuvant chemoradiotherapy improves survival in patients with locoregional esophageal cancer. This study compares the efficacy of two common regimens, paclitaxel plus platinum and platinum plus 5-fluorouracil, based on overall survival. ⋯ Neoadjuvant chemoradiotherapy with paclitaxel plus platinum regimen seemed to be a better treatment than platinum plus 5-fluorouracil regimen for locoregional esophageal cancer, especially for squamous cell carcinoma.